NCT00003646View on ClinicalTrials.gov

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

PHASE2CompletedINTERVENTIONAL

Enrollment

78

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

March 31, 2002

Study Completion Date

May 31, 2002

Conditions

Stage IV MelanomaStage III MelanomaRecurrent Melanoma

Interventions

DRUG

allovectin-7

Trial Locations (3)

55905

Mayo Clinic Cancer Center, Rochester

75246

Physician Reliance Network, Inc., Dallas

14263-0001

Roswell Park Cancer Institute, Buffalo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Vical

INDUSTRY

NCT00003646 - Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma | Biotech Hunter | Biotech Hunter